Açık Akademik Arşiv Sistemi

The Real-World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL

Show simple item record

dc.date.accessioned 2023-03-06T07:33:11Z
dc.date.available 2023-03-06T07:33:11Z
dc.date.issued 2022
dc.identifier.citation Clin Lymphoma Myeloma Leuk. 2022 Mar;22(3):169-173. doi: 10.1016/j.clml.2021.09.010. Epub 2021 Sep 15.
dc.identifier.uri https://hdl.handle.net/20.500.12619/100565
dc.relation.isversionof 10.1016/j.clml.2021.09.010
dc.relation.isversionof 10.1016/j.clml.2021.09.010
dc.title The Real-World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL
dc.relation.journal Clin Lymphoma Myeloma Leuk
dc.identifier.doi 10.1016/j.clml.2021.09.010
dc.contributor.author Akpinar S
dc.contributor.author Akpinar S
dc.contributor.author Dogu MH
dc.contributor.author Celik S
dc.contributor.author Ekinci O
dc.contributor.author Hindilerden IY
dc.contributor.author Dal MS
dc.contributor.author Davulcu EA


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record